A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
1 other identifier
observational
23
1 country
1
Brief Summary
Growing evidence shows that altered blood flow plays a major role in many vision-threatening diseases including glaucoma, diabetic retinopathy, age-related macular degeneration, Central Retinal Vein Occlusion, and Branch Retinal Vein Occlusion. Optical coherence tomography, an established imaging technique use for eye exam in clinical ophthalmology, provides high-resolution cross sectional images of the retina and has increased our ability to understand many eye diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 7, 2007
CompletedFirst Posted
Study publicly available on registry
November 9, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedOctober 20, 2022
October 1, 2022
6.5 years
November 7, 2007
October 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medical exam tool
Optical Coherence Tomography imaging technique of the retina and ability to diagnose and manage many eye diseases
24 hours
Study Arms (1)
Optical Coherence Tomography
Optical Coherence Tomography
Interventions
Eligibility Criteria
Primary care clinic and community sample.
You may qualify if:
- Adult 18 years and older with normal eye, or has been diagnosed with eye disease.
You may not qualify if:
- Less than 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beckman Laser Institute, University of California,Irvine
Irvine, California, 02612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Baruch D Kuppermann,, M.D., Ph.D.
Ophthamology, University of California,Irvine
- PRINCIPAL INVESTIGATOR
Zhongping Chen, Ph,D
Beckman Laser Institute University of California Irvine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Baruch D. Kuppermann, M.D., Ph.D.,Professor Department of Ophthalmology and Biomedical Engineering
Study Record Dates
First Submitted
November 7, 2007
First Posted
November 9, 2007
Study Start
January 1, 2007
Primary Completion
July 1, 2013
Study Completion
July 1, 2013
Last Updated
October 20, 2022
Record last verified: 2022-10